Pharmaceutical-Industry

Does Pfizer Offer Good Value?

Over the past 12 months, Pfizer has underperformed the S&P 500 by a wide margin. The company is just 4.6% ahead of the benchmark over...

Why Alexion Pharmaceuticals, Gilead Sciences, and Monster Beverage Corporation Are Today's 3 Worst S

After about seven out of every 10 stocks added ground yesterday, I opened my evening article with a simple sentence: "It was ...

Dow Plummets 266 Points on Tech, Biotech Selloff; Rite Aid Surges

After a short, two-day reprieve that saw the Dow Jones Industrial Average gain nearly 200 points, the bears returned in full...

2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals

Although 2014 has gotten off to a rocky start for biotechs, a fair number of companies have exploded higher after reporting positive clinical...

S&P 500 Dividend Aristocrats: Reliably Growing Dividends

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some solid...

Why Celladon Corp. Shares Are Pumped Up

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in...

Agios Taps Wall Street Off Early Data, Aims For $75M

Agios Pharmaceuticals gave investors its first glimpse of encouraging, but early human clinical data a few days ago, and saw its...

3 Breast Cancer Drugs With Big Potential

In 2010, $16.5 billion was spent on breast cancer treatment in the U.S. and as much as $25 billion could be spent treating the disease by...

Today's Biotech Stocks to Watch: Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Inc.

Let's take a look at today's top stories in biotech and health care. Keep an eye out for Bristol-Myers SquibbGilead Sciences...

New Painkiller Banned: Massachusetts Fallout

Zoegenics' Zohydro has been contentious since well before its approval by the FDA. After all, the FDA's advisory committee voted...